Table II.
Methylation | Patient n=125 (%) | Control n=100 (%) | OR (95% CI) | P-value |
---|---|---|---|---|
p14ARF | 11 (8.8) | 2 (2) | 1.57 (1.21–2.05) | 0.059 |
p15INK4b | 14 (11.2) | 3 (3) | 1.54 (1.20–1.99) | 0.03 |
p16INK4a | 45 (36) | 1 (1) | 2.19 (1.85–2.59) | 0.000 |
Methylation | Patient n=125 (%) | Control n=100 (%) | OR (95% CI) | P-value |
---|---|---|---|---|
p14ARF | 11 (8.8) | 2 (2) | 1.57 (1.21–2.05) | 0.059 |
p15INK4b | 14 (11.2) | 3 (3) | 1.54 (1.20–1.99) | 0.03 |
p16INK4a | 45 (36) | 1 (1) | 2.19 (1.85–2.59) | 0.000 |